|View printer-friendly version|
|Array BioPharma to Report Financial Results for the First Quarter of Fiscal 2009 on November 3, 2008|
BOULDER, Colo.--(BUSINESS WIRE)--Oct. 27, 2008--Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the first quarter of fiscal 2009 on Monday, November 3, 2008, and will hold a conference call on Tuesday, November 4, 2008, at 9:00 a.m. Eastern time to discuss these results. Robert E. Conway, Chief Executive Officer, and Michael Carruthers, Chief Financial Officer, will lead the call.
Conference Call Information Date: Tuesday, November 4, 2008 Time: 9:00 a.m. Eastern time Toll-Free: 877-719-9810 Toll: 719-325-4808 Pass Code: 1160404 Web Cast: www.arraybiopharma.com
A replay of the call will be available as a webcast on www.arraybiopharma.com and by phone for one week by dialing toll-free 888-203-1112 or 719-457-0820. The access code is 1160404.
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer, inflammatory and metabolic diseases. Our proprietary drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target proteins and are aimed at large market opportunities. In addition, leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas. For more information on Array, please go to www.arraybiopharma.com.
CONTACT: Array BioPharma Inc. Tricia Haugeto, 303-386-1193 firstname.lastname@example.org SOURCE: Array BioPharma Inc.